Electronic health records: Implications for drug discovery

Lixia Yao, Yiye Zhang, Yong Li, Philippe Sanseau, Pankaj Agarwal

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Electronic health records (EHRs) have increased in popularity in many countries. Pushed by legal mandates, EHR systems have seen substantial progress recently, including increasing adoption of standards, improved medical vocabularies and enhancements in technical infrastructure for data sharing across healthcare providers. Although the progress is directly beneficial to patient care in a hospital or clinical setting, it can also aid drug discovery. In this article, we review three specific applications of EHRs in a drug discovery context: finding novel relationships between diseases, re-evaluating drug usage and discovering phenotype-genotype associations. We believe that in the near future EHR systems and related databases will impact significantly how we discover and develop safe and efficacious medicines.

Original languageEnglish (US)
Pages (from-to)594-599
Number of pages6
JournalDrug Discovery Today
Volume16
Issue number13-14
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Electronic Health Records
Drug Discovery
Information Dissemination
Vocabulary
Genetic Association Studies
Health Personnel
Patient Care
Databases
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Electronic health records : Implications for drug discovery. / Yao, Lixia; Zhang, Yiye; Li, Yong; Sanseau, Philippe; Agarwal, Pankaj.

In: Drug Discovery Today, Vol. 16, No. 13-14, 01.07.2011, p. 594-599.

Research output: Contribution to journalReview article

Yao, L, Zhang, Y, Li, Y, Sanseau, P & Agarwal, P 2011, 'Electronic health records: Implications for drug discovery', Drug Discovery Today, vol. 16, no. 13-14, pp. 594-599. https://doi.org/10.1016/j.drudis.2011.05.009
Yao, Lixia ; Zhang, Yiye ; Li, Yong ; Sanseau, Philippe ; Agarwal, Pankaj. / Electronic health records : Implications for drug discovery. In: Drug Discovery Today. 2011 ; Vol. 16, No. 13-14. pp. 594-599.
@article{1b1ded3197bd470ca535b25eb4b979bb,
title = "Electronic health records: Implications for drug discovery",
abstract = "Electronic health records (EHRs) have increased in popularity in many countries. Pushed by legal mandates, EHR systems have seen substantial progress recently, including increasing adoption of standards, improved medical vocabularies and enhancements in technical infrastructure for data sharing across healthcare providers. Although the progress is directly beneficial to patient care in a hospital or clinical setting, it can also aid drug discovery. In this article, we review three specific applications of EHRs in a drug discovery context: finding novel relationships between diseases, re-evaluating drug usage and discovering phenotype-genotype associations. We believe that in the near future EHR systems and related databases will impact significantly how we discover and develop safe and efficacious medicines.",
author = "Lixia Yao and Yiye Zhang and Yong Li and Philippe Sanseau and Pankaj Agarwal",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.drudis.2011.05.009",
language = "English (US)",
volume = "16",
pages = "594--599",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "13-14",

}

TY - JOUR

T1 - Electronic health records

T2 - Implications for drug discovery

AU - Yao, Lixia

AU - Zhang, Yiye

AU - Li, Yong

AU - Sanseau, Philippe

AU - Agarwal, Pankaj

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Electronic health records (EHRs) have increased in popularity in many countries. Pushed by legal mandates, EHR systems have seen substantial progress recently, including increasing adoption of standards, improved medical vocabularies and enhancements in technical infrastructure for data sharing across healthcare providers. Although the progress is directly beneficial to patient care in a hospital or clinical setting, it can also aid drug discovery. In this article, we review three specific applications of EHRs in a drug discovery context: finding novel relationships between diseases, re-evaluating drug usage and discovering phenotype-genotype associations. We believe that in the near future EHR systems and related databases will impact significantly how we discover and develop safe and efficacious medicines.

AB - Electronic health records (EHRs) have increased in popularity in many countries. Pushed by legal mandates, EHR systems have seen substantial progress recently, including increasing adoption of standards, improved medical vocabularies and enhancements in technical infrastructure for data sharing across healthcare providers. Although the progress is directly beneficial to patient care in a hospital or clinical setting, it can also aid drug discovery. In this article, we review three specific applications of EHRs in a drug discovery context: finding novel relationships between diseases, re-evaluating drug usage and discovering phenotype-genotype associations. We believe that in the near future EHR systems and related databases will impact significantly how we discover and develop safe and efficacious medicines.

UR - http://www.scopus.com/inward/record.url?scp=79959710692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959710692&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2011.05.009

DO - 10.1016/j.drudis.2011.05.009

M3 - Review article

C2 - 21624499

AN - SCOPUS:79959710692

VL - 16

SP - 594

EP - 599

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 13-14

ER -